Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24520094

Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2014 Mar 1
First author
Kushner BH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kushner BH
      type
      Author
    2. name
      Cheung IY
      type
      Author
    3. name
      Modak S
      type
      Author
    4. name
      Kramer K
      type
      Author
    5. name
      Ragupathi G
      type
      Author
    6. name
      Cheung NK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kushner BH
      type
      Author
    2. name
      Cheung IY
      type
      Author
    3. name
      Modak S
      type
      Author
    4. name
      Kramer K
      type
      Author
    5. name
      Ragupathi G
      type
      Author
    6. name
      Cheung NK
      type
      Author
    bibliography ids
    1. nci-bib-15f32eead088bae26441e31b
    book metadata
    content sha256
    f4de3fb373e8e22185d09208f8b205070c8cf9dd8da78fac0c00f63411f1d584
    document type
    citation
    dois
    1. 10.1158/1078-0432.CCR-13-1012
    electronic publication date
    display
    2014 Feb 11
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24520094
    immutable id
    pubmed:24520094@f4de3fb373e8e22185d09208f8b205070c8cf9dd8da78fac0c00f63411f1d584
    journal
    abbreviation
    Clin Cancer Res
    issn electronic
    1557-3265
    issn print
    1078-0432
    issue
    5
    name
    Clinical cancer research : an official journal of the American Association for Cancer Research
    nlm unique id
    9502500
    pages
    1375-82
    volume
    20
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24520094
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      3cc6f46599a7508897797c01cf261f341c9dc698a6c974d638e06b386e22d948
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2014 Mar 1
      precision
      day
      year
      2014
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24520094/
      title
      Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.

      Preserved source evidence · Not medical advice